Perdagangan Bright Health Group Inc. - BHG CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.0009 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.024068% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.001846% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | 0.2377 |
Open* | 0.2388 |
1-Year Change* | -89.24% |
Day's Range* | 0.2141 - 0.2388 |
52 wk Range | 0.22-2.40 |
Average Volume (10 days) | 5.01M |
Average Volume (3 months) | 51.14M |
Market Cap | 138.74M |
P/E Ratio | -100.00K |
Shares Outstanding | 630.33M |
Revenue | 2.41B |
EPS | -1.23 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 24, 2023 | 0.2196 | -0.0192 | -8.04% | 0.2388 | 0.2397 | 0.2098 |
Mar 23, 2023 | 0.2377 | -0.0211 | -8.15% | 0.2588 | 0.2607 | 0.2230 |
Mar 22, 2023 | 0.2497 | -0.0189 | -7.04% | 0.2686 | 0.2717 | 0.2497 |
Mar 21, 2023 | 0.2651 | 0.0054 | 2.08% | 0.2597 | 0.2830 | 0.2597 |
Mar 20, 2023 | 0.2558 | -0.0128 | -4.77% | 0.2686 | 0.2750 | 0.2495 |
Mar 17, 2023 | 0.2629 | -0.0455 | -14.75% | 0.3084 | 0.3086 | 0.2494 |
Mar 16, 2023 | 0.3080 | -0.0502 | -14.01% | 0.3582 | 0.3596 | 0.2722 |
Mar 15, 2023 | 0.3550 | 0.0068 | 1.95% | 0.3482 | 0.3905 | 0.3371 |
Mar 14, 2023 | 0.3420 | -0.0461 | -11.88% | 0.3881 | 0.3896 | 0.3419 |
Mar 13, 2023 | 0.3765 | 0.0183 | 5.11% | 0.3582 | 0.4095 | 0.3368 |
Mar 10, 2023 | 0.3697 | -0.0377 | -9.25% | 0.4074 | 0.4074 | 0.3314 |
Mar 9, 2023 | 0.3718 | -0.0837 | -18.38% | 0.4555 | 0.4555 | 0.3561 |
Mar 8, 2023 | 0.4485 | -0.0397 | -8.13% | 0.4882 | 0.4882 | 0.4478 |
Mar 7, 2023 | 0.4814 | 0.0236 | 5.16% | 0.4578 | 0.5104 | 0.4439 |
Mar 6, 2023 | 0.4571 | -0.0056 | -1.21% | 0.4627 | 0.4895 | 0.4220 |
Mar 3, 2023 | 0.4469 | -0.0407 | -8.35% | 0.4876 | 0.4896 | 0.4325 |
Mar 2, 2023 | 0.4869 | -0.0817 | -14.37% | 0.5686 | 0.5872 | 0.4795 |
Mar 1, 2023 | 0.5394 | -0.2368 | -30.51% | 0.7762 | 0.7762 | 0.5394 |
Feb 28, 2023 | 0.8717 | 0.0657 | 8.15% | 0.8060 | 0.9192 | 0.8060 |
Feb 27, 2023 | 0.7947 | 0.0354 | 4.66% | 0.7593 | 0.8359 | 0.7369 |
Bright Health Group Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Total revenue | 4029.39 | 1207.32 | 280.673 | 130.632 |
Total Operating Expense | 5227.54 | 1464.92 | 406.01 | 193.273 |
Selling/General/Admin. Expenses, Total | 995.814 | 339.276 | 151.644 | 84.831 |
Depreciation / Amortization | 35.484 | 8.289 | 1.134 | 1.03 |
Unusual Expense (Income) | 6.338 | 4.95 | 1.248 | 0 |
Other Operating Expenses, Total | 236.235 | 65.108 | 27.597 | 11.005 |
Operating Income | -1198.16 | -257.603 | -125.337 | -62.641 |
Net Income Before Taxes | -1204.89 | -257.603 | -125.337 | -62.641 |
Net Income After Taxes | -1178.36 | -248.442 | -125.337 | -62.641 |
Net Income Before Extra. Items | -1184.86 | -248.442 | -125.337 | -62.641 |
Net Income | -1184.86 | -248.442 | -125.337 | -62.641 |
Income Available to Common Excl. Extra. Items | -1184.86 | -248.442 | -125.337 | -62.641 |
Income Available to Common Incl. Extra. Items | -1184.86 | -248.442 | -125.337 | -62.641 |
Diluted Net Income | -1184.86 | -248.442 | -125.337 | -62.641 |
Diluted Weighted Average Shares | 392.243 | 615.37 | 615.37 | 615.37 |
Diluted EPS Excluding Extraordinary Items | -3.02073 | -0.40373 | -0.20368 | -0.10179 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
Diluted Normalized EPS | -2.99366 | -0.3985 | -0.20165 | -0.10179 |
Total Premiums Earned | 3945.42 | 1198.85 | 272.323 | 127.122 |
Net Investment Income | 4.074 | 8.468 | 8.35 | 3.51 |
Losses, Benefits, and Adjustments, Total | 3953.67 | 1047.3 | 224.387 | 96.407 |
Other Revenue, Total | 80.3 | |||
Interest Income (Expense), Net Non-Operating | -7.956 | |||
Other, Net | 1.226 | |||
Minority Interest | -6.497 | |||
Realized Gains (Losses) | -0.4 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total revenue | 1835.57 | 962.334 | 1078.66 | 1113.84 | 874.558 |
Total Operating Expense | 2012.56 | 1782.33 | 1374.94 | 1172.89 | 897.391 |
Depreciation / Amortization | 13.041 | 9.503 | 14.205 | 7.195 | 4.581 |
Unusual Expense (Income) | 0.111 | 0.74 | 0.448 | 3.13 | 2.02 |
Other Operating Expenses, Total | 87.412 | 183.724 | 78.354 | 74.26 | 206.22 |
Operating Income | -176.98 | -819.997 | -296.281 | -59.045 | -22.833 |
Interest Income (Expense), Net Non-Operating | -1.193 | -1.674 | -1.594 | -4.142 | -0.546 |
Net Income Before Taxes | -177.389 | -821.671 | -296.649 | -63.187 | -23.379 |
Net Income After Taxes | -180.629 | -813.375 | -296.722 | -43.723 | -24.545 |
Minority Interest | -14.605 | -1.143 | -3.942 | -0.795 | -0.617 |
Net Income Before Extra. Items | -195.234 | -814.518 | -300.664 | -44.518 | -25.162 |
Net Income | -195.234 | -814.518 | -300.664 | -44.518 | -25.162 |
Income Available to Common Excl. Extra. Items | -204.172 | -814.518 | -300.664 | -44.518 | -25.162 |
Income Available to Common Incl. Extra. Items | -204.172 | -814.518 | -300.664 | -44.518 | -25.162 |
Diluted Net Income | -204.172 | -814.518 | -300.664 | -44.518 | -25.162 |
Diluted Weighted Average Shares | 628.765 | 632.09 | 630.378 | 625.691 | 615.37 |
Diluted EPS Excluding Extraordinary Items | -0.32472 | -1.28861 | -0.47696 | -0.07115 | -0.04089 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.3098 | -1.28785 | -0.46619 | -0.0679 | -0.03876 |
Total Premiums Earned | 1875.68 | 990.863 | 1031.31 | 1054.17 | 869.069 |
Net Investment Income | -40.1 | -28.529 | 47.345 | 59.669 | 5.489 |
Losses, Benefits, and Adjustments, Total | 1580.6 | 1313.53 | 1050.94 | 904.63 | 684.57 |
Selling/General/Admin. Expenses, Total | 331.395 | 274.833 | 230.988 | 183.67 | |
Other, Net | 0.784 | 0 | 1.226 | ||
Total Adjustments to Net Income | -8.938 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Cash & Equivalents | 1061.18 | 488.371 | 522.91 | |
Prepaid Expenses | 291.712 | 130.986 | 17.221 | |
Total Assets | 3598.34 | 1810.8 | 820.355 | |
Property/Plant/Equipment, Total - Net | 83.689 | 39.229 | 17.259 | |
Property/Plant/Equipment, Total - Gross | 47.025 | 17.511 | 5.599 | |
Accumulated Depreciation, Total | -8.681 | -5.247 | -2.368 | |
Goodwill, Net | 835.14 | 263.035 | 20.125 | |
Intangibles, Net | 343.86 | 152.211 | 18.712 | |
Long Term Investments | 675.192 | 175.176 | 115.348 | |
Other Long Term Assets, Total | 193.835 | 499.928 | 107.682 | |
Other Assets, Total | 0.258 | 1.344 | 0.311 | |
Accounts Payable | 118.14 | 57.252 | 33.143 | |
Accrued Expenses | 50.266 | 28.42 | 14.47 | |
Notes Payable/Short Term Debt | 155 | 0 | 0 | |
Other Current Liabilities, Total | 931.17 | 187.777 | 86.803 | |
Total Liabilities | 2453.22 | 633.459 | 211.732 | |
Total Long Term Debt | 0 | 0 | 0 | |
Minority Interest | 128.407 | 39.6 | 0 | |
Other Liabilities, Total | 198.966 | 36.005 | 16.507 | |
Total Equity | 1145.12 | 1177.34 | 608.623 | |
Redeemable Preferred Stock | 0 | 1681.02 | 871.99 | |
Common Stock | 0.063 | 0.014 | 0.014 | |
Additional Paid-In Capital | 2861.24 | 9.877 | 3.184 | |
Retained Earnings (Accumulated Deficit) | -1700.85 | -515.989 | -267.547 | |
Unrealized Gain (Loss) | -3.335 | 2.426 | 0.982 | |
Total Liabilities & Shareholders’ Equity | 3598.34 | 1810.8 | 820.355 | |
Total Common Shares Outstanding | 626.101 | 615.37 | 615.37 | |
Treasury Stock - Common | -12 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Cash & Equivalents | 1505.55 | 1061.18 | 956.189 | 1506.32 | 975.933 |
Prepaid Expenses | 315.422 | 291.712 | 240.545 | 208.693 | 157.278 |
Total Assets | 5275.03 | 3598.34 | 3575.09 | 3599.78 | 2488.12 |
Property/Plant/Equipment, Total - Net | 41.279 | 38.344 | 30.932 | 19.101 | 15.784 |
Goodwill, Net | 835.45 | 835.14 | 842.301 | 565.02 | 328.983 |
Intangibles, Net | 326.617 | 343.86 | 351.519 | 262.42 | 166.726 |
Long Term Investments | 733.465 | 675.192 | 681.923 | 633.029 | 453.146 |
Other Long Term Assets, Total | 692.472 | 193.835 | 331.719 | 283.337 | 274.578 |
Other Assets, Total | 43.438 | 45.603 | 40.751 | 28.773 | 30.204 |
Accounts Payable | 128.407 | 118.14 | 95.161 | 86.527 | 85.146 |
Notes Payable/Short Term Debt | 0 | 155 | 0 | 0 | 200 |
Other Current Liabilities, Total | 1285.45 | 931.17 | 548.352 | 507.853 | 326.31 |
Total Liabilities | 3570.82 | 2453.22 | 1637.89 | 1449.75 | 1271.77 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 5.716 |
Long Term Debt | 5.716 | ||||
Minority Interest | 143.011 | 128.407 | 130.029 | 41.012 | 40.217 |
Other Liabilities, Total | 823.909 | 249.232 | 144.387 | 210.68 | 86.214 |
Total Equity | 1704.2 | 1145.12 | 1937.2 | 2150.03 | 1216.34 |
Redeemable Preferred Stock | 747.481 | 0 | 1736.15 | ||
Common Stock | 0.063 | 0.063 | 0.063 | 0.063 | 0.014 |
Additional Paid-In Capital | 2894.42 | 2861.24 | 2823.24 | 2735.1 | 19.946 |
Retained Earnings (Accumulated Deficit) | -1896.08 | -1700.85 | -886.333 | -585.669 | -541.151 |
Unrealized Gain (Loss) | -29.675 | -3.335 | 0.23 | 0.533 | 1.384 |
Total Liabilities & Shareholders’ Equity | 5275.03 | 3598.34 | 3575.09 | 3599.78 | 2488.12 |
Total Common Shares Outstanding | 626.47 | 626.101 | 628.134 | 625.691 | 615.37 |
Treasury Stock - Common | -12 | -12 | |||
Total Receivables, Net | 638.641 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Net income/Starting Line | -1184.86 | -248.442 | -125.337 | -62.641 |
Cash From Operating Activities | 82.059 | -57.238 | -8.208 | -27.034 |
Cash From Operating Activities | 35.484 | 8.289 | 1.134 | 1.03 |
Non-Cash Items | 8.446 | 8.119 | 0.533 | 0.346 |
Changes in Working Capital | 1248.65 | 174.796 | 115.462 | 34.231 |
Cash From Investing Activities | -552.892 | -689.742 | -94.643 | -6.94 |
Capital Expenditures | -30.414 | -6.474 | -0.793 | -0.694 |
Other Investing Cash Flow Items, Total | -522.478 | -683.268 | -93.85 | -6.246 |
Cash From Financing Activities | 1043.64 | 712.441 | 424.06 | 203.057 |
Issuance (Retirement) of Stock, Net | 898.718 | 712.441 | 424.06 | 203.057 |
Net Change in Cash | 572.808 | -34.539 | 321.209 | 169.083 |
Deferred Taxes | -25.654 | |||
Cash Interest Paid | 4.592 | |||
Financing Cash Flow Items | -10.077 | |||
Issuance (Retirement) of Debt, Net | 155 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -180.629 | -1184.86 | -370.344 | -69.68 | -25.162 |
Cash From Operating Activities | 484.757 | 82.059 | 233.114 | 497.146 | 343.603 |
Cash From Operating Activities | 13.041 | 35.484 | 25.981 | 11.776 | 4.581 |
Deferred Taxes | 0.717 | -25.654 | -17.946 | -18.018 | 1.166 |
Non-Cash Items | 82.987 | 8.446 | -51.223 | -35.019 | 7.87 |
Cash Interest Paid | 1.168 | 4.592 | 3.865 | 3.195 | 0.244 |
Changes in Working Capital | 568.641 | 1248.65 | 646.646 | 608.087 | 355.148 |
Cash From Investing Activities | -633.127 | -552.892 | -653.128 | -368.221 | -56.275 |
Capital Expenditures | -5.491 | -30.414 | -20.682 | -10.554 | -4.215 |
Other Investing Cash Flow Items, Total | -627.636 | -522.478 | -632.446 | -357.667 | -52.06 |
Cash From Financing Activities | 592.738 | 1043.64 | 887.832 | 889.023 | 200.234 |
Financing Cash Flow Items | 0 | -10.077 | -10.077 | -7.921 | -4.659 |
Issuance (Retirement) of Stock, Net | 747.738 | 898.718 | 897.909 | 896.944 | 4.893 |
Issuance (Retirement) of Debt, Net | -155 | 155 | 0 | 0 | 200 |
Net Change in Cash | 444.368 | 572.808 | 467.818 | 1017.95 | 487.562 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
New Enterprise Associates (NEA) | Venture Capital | 34.6094 | 218153623 | -141152210 | 2022-12-31 | LOW |
Bessemer Venture Partners | Venture Capital | 12.6819 | 79937724 | 624252 | 2022-12-31 | LOW |
StepStone Group LP | Private Equity | 6.6667 | 42022244 | 336964 | 2022-12-31 | LOW |
Sheehy (Robert J) | Individual Investor | 3.1817 | 20055236 | 0 | 2023-03-01 | LOW |
Redpoint Ventures | Venture Capital | 2.4067 | 15169998 | 0 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.0013 | 12614663 | 590226 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.8511 | 11668037 | 42776 | 2022-12-31 | LOW |
Greycroft LP | Investment Advisor | 1.7559 | 11068221 | 0 | 2022-12-31 | LOW |
Meritech Capital Partners | Venture Capital | 1.6817 | 10600380 | 0 | 2022-12-31 | LOW |
Slavitt (Andrew M) | Individual Investor | 1.1596 | 7309356 | 0 | 2023-03-01 | LOW |
Partners Group AG | Private Equity | 1.1251 | 7091646 | 0 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.8604 | 5423309 | 2076279 | 2022-12-31 | LOW |
Valdivia (Tomas M.D.) | Individual Investor | 0.7155 | 4510050 | 4510050 | 2021-06-28 | |
HarbourVest Partners, L.L.C. | Private Equity | 0.6691 | 4217715 | 0 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6263 | 3948005 | 72887 | 2022-12-31 | LOW |
Blackstone Tactical Opportunities Advisors L.L.C. | Hedge Fund | 0.5828 | 3673284 | 0 | 2022-12-31 | LOW |
Legacy Wealth Asset Management, LLC | Investment Advisor | 0.5719 | 3604587 | -842946 | 2022-12-31 | MED |
Cross Creek Advisors, LLC | Venture Capital | 0.5611 | 3536600 | 0 | 2022-12-31 | MED |
Nuveen LLC | Pension Fund | 0.3737 | 2355491 | 195937 | 2022-12-31 | LOW |
Folick (Jeffrey M) | Individual Investor | 0.3034 | 1912307 | 1912307 | 2021-06-28 |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group500K+
Trader
92K+
Klien aktif per bulan
$53M+
Volume investasi per bulan
$30M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Life & Health Insurance (NEC) |
8000 Norman Center Drive
Suite 900
MINNEAPOLIS
MINNESOTA 55437
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com